Page last updated: 2024-12-05
n-ethyl-n-nitrosourethane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11977 |
SCHEMBL ID | 3499661 |
MeSH ID | M0079513 |
Synonyms (49)
Synonym |
---|
unii-0roq23ij4f |
0roq23ij4f , |
hsdb 7862 |
ethylester kyseliny n-ethyl-n-nitrosokarbaminove |
614-95-9 |
nitroso-n-ethylurethane |
nitrosoethylurethane |
nsc 24890 |
nsc24890 |
n-ethyl-n-nitrosourethan |
ethyl ethylnitrosocarbamate |
ethyl nitrosourethan |
aethylnitrosourethan |
ethyl n-ethylnitrosocarbamate |
ethylnitrosocarbamic acid ethyl ester |
n-ethyl-n-nitrosourethane |
wln: onn2&vo2 |
ethylnitrosocarbamic acid, ethyl ester |
nsc-24890 |
ethyl n-ethyl-n-nitrosourethane |
ethylnitrosourethane |
n-nitroso-n-ethylurethan |
n-ethyl-n-nitrosocarbamic acid, ethyl ester |
nitrosoethylurethan |
n-nitrosoethylurethane |
n,n-nitrosoethylurethane |
n-nitroso-n-ethylurethane |
ethyl ethyl(nitroso)carbamate |
aethylnitrosourethan [german] |
ethyl nitrosourethane |
n-ethyl-n-nitrosocarbamic acid ethyl ester |
brn 1764259 |
ai3-16184 |
ethylnitrosourethan |
carbamic acid, ethylnitroso-, ethyl ester |
ccris 1376 |
ethylester kyseliny n-ethyl-n-nitrosokarbaminove [czech] |
ethyl n-ethyl-n-nitroso-carbamate |
ethyl n-ethyl-n-nitrosocarbamate |
AKOS006272647 |
SCHEMBL3499661 |
carbamic acid, n-ethyl-n-nitroso-, ethyl ester |
n-ethyl-n-nitrosourethane [hsdb] |
RAUQLNDTFONODT-UHFFFAOYSA-N |
ethyl 1-ethyl-2-oxohydrazinecarboxylate # |
n-nitro-n-ethylurethane |
DTXSID1021037 |
carbamic acid, ethylnitroso-ethyl ester |
Q27237148 |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
"A dose-response study on the carcinogenicity of N-ethyl-N-nitrosourethane (ENUR) was undertaken to examine its effect at low doses." | ( Dose-response carcinogenicity in rats on low-dose levels of N-ethyl-N-nitrosourethane. Hayashi, Y; Kodama, Y; Maekawa, A; Matsushima, Y; Nagaoka, T; Onodera, H; Shibutani, M; Todate, A, 1989) | 0.77 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.79) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |